Vaxcyte (PCVX) Interest & Investment Income (2019 - 2026)
Vaxcyte's (PCVX) quarterly Interest & Investment Income came in at $26.6 million in Q1 2026, down 19.2% year-on-year from $32.9 million in Q1 2025, and up 0.6% on a QoQ basis from $26.5 million in Q4 2025.
Vaxcyte (PCVX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Interest & Investment Income data on file, last reported at $26.6 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 19.2% year-over-year to $26.6 million in Q1 2026; TTM through Mar 2026 was $113.4 million, a 6.49% decrease from a year earlier, with the FY2025 full-year figure at $119.7 million, up 8.84% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $26.6 million, up from $26.5 million in the prior quarter.
- Over the last five years, Interest & Investment Income for PCVX reached as high as $36.5 million in Q4 2024 and fell as low as -$592000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $19.2 million across 5 years, with a median of $21.7 million in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 6600.0% in 2022 and fell as far as 1070.49% in 2022.
- Year by year, Interest & Investment Income stood at $6.6 million in 2022, then jumped by 164.86% to $17.6 million in 2023, then surged by 107.53% to $36.5 million in 2024, then fell by 27.45% to $26.5 million in 2025, then advanced by 0.6% to $26.6 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $26.6 million in Q1 2026, $26.5 million in Q4 2025, and $29.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Vaxcyte | 7.74 Bn | 7.74 Bn | - | 26.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.61 Mn |
| Dec 31, 2025 | 26.45 Mn |
| Sep 30, 2025 | 29.26 Mn |
| Jun 30, 2025 | 31.07 Mn |
| Mar 31, 2025 | 32.94 Mn |
| Dec 31, 2024 | 36.46 Mn |
| Sep 30, 2024 | 28.06 Mn |
| Jun 30, 2024 | 23.81 Mn |
| Mar 31, 2024 | 21.67 Mn |
| Dec 31, 2023 | 17.57 Mn |
| Sep 30, 2023 | 18.50 Mn |
| Jun 30, 2023 | 16.45 Mn |
| Mar 31, 2023 | 10.39 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | -592,000.00 |
| Dec 31, 2021 | 99,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 93,000.00 |